556 related articles for article (PubMed ID: 23497468)
21. Alcohol consumption in relation to plasma sex hormones, prolactin, and sex hormone-binding globulin in premenopausal women.
Hirko KA; Spiegelman D; Willett WC; Hankinson SE; Eliassen AH
Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2943-53. PubMed ID: 25281368
[TBL] [Abstract][Full Text] [Related]
22. Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case-cohort analysis.
Albers FEM; Lou MWC; Dashti SG; Swain CTV; Rinaldi S; Viallon V; Karahalios A; Brown KA; Gunter MJ; Milne RL; English DR; Lynch BM
Cancer Causes Control; 2024 Jun; 35(6):921-933. PubMed ID: 38363402
[TBL] [Abstract][Full Text] [Related]
23. Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women - exercise and premenopausal hormones.
Tworoger SS; Missmer SA; Eliassen AH; Barbieri RL; Dowsett M; Hankinson SE
Cancer Causes Control; 2007 Sep; 18(7):743-52. PubMed ID: 17549594
[TBL] [Abstract][Full Text] [Related]
24. Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women.
Falk RT; Gentzschein E; Stanczyk FZ; Garcia-Closas M; Figueroa JD; Ioffe OB; Lissowska J; Brinton LA; Sherman ME
Breast Cancer Res Treat; 2012 Jan; 131(1):287-94. PubMed ID: 21870130
[TBL] [Abstract][Full Text] [Related]
25. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Allen NE; Key TJ; Dossus L; Rinaldi S; Cust A; Lukanova A; Peeters PH; Onland-Moret NC; Lahmann PH; Berrino F; Panico S; Larrañaga N; Pera G; Tormo MJ; Sánchez MJ; Ramón Quirós J; Ardanaz E; Tjønneland A; Olsen A; Chang-Claude J; Linseisen J; Schulz M; Boeing H; Lundin E; Palli D; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Bingham S; Khaw KT; Bueno-de-Mesquita HB; Trichopoulou A; Trichopoulos D; Naska A; Tumino R; Riboli E; Kaaks R
Endocr Relat Cancer; 2008 Jun; 15(2):485-97. PubMed ID: 18509001
[TBL] [Abstract][Full Text] [Related]
26. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
[TBL] [Abstract][Full Text] [Related]
27. A prospective study of endogenous estrogens and breast cancer in postmenopausal women.
Toniolo PG; Levitz M; Zeleniuch-Jacquotte A; Banerjee S; Koenig KL; Shore RE; Strax P; Pasternack BS
J Natl Cancer Inst; 1995 Feb; 87(3):190-7. PubMed ID: 7707406
[TBL] [Abstract][Full Text] [Related]
28. Recreational physical activity and breast cancer risk by menopausal status and tumor hormone receptor status: results from the Nurses' Health Studies.
Fortner RT; Brantley KD; Tworoger SS; Tamimi RM; Rosner B; Holmes MD; Willett WC; Eliassen AH
Breast Cancer Res Treat; 2024 Jul; 206(1):77-90. PubMed ID: 38592542
[TBL] [Abstract][Full Text] [Related]
29. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies.
; Key TJ; Appleby PN; Reeves GK; Travis RC; Alberg AJ; Barricarte A; Berrino F; Krogh V; Sieri S; Brinton LA; Dorgan JF; Dossus L; Dowsett M; Eliassen AH; Fortner RT; Hankinson SE; Helzlsouer KJ; Hoff man-Bolton J; Comstock GW; Kaaks R; Kahle LL; Muti P; Overvad K; Peeters PH; Riboli E; Rinaldi S; Rollison DE; Stanczyk FZ; Trichopoulos D; Tworoger SS; Vineis P
Lancet Oncol; 2013 Sep; 14(10):1009-19. PubMed ID: 23890780
[TBL] [Abstract][Full Text] [Related]
30. Does the increase of endogenous steroid hormone levels also affect breast cancer risk in Chinese women? A case-control study in Chongqing, China.
Wang B; Mi M; Wang J; Wei N; Zhang Q; Zhu J; Yang S; Guo B; Xu J; Yang X
Int J Cancer; 2009 Apr; 124(8):1892-9. PubMed ID: 19117053
[TBL] [Abstract][Full Text] [Related]
31. Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women.
Fourkala EO; Zaikin A; Burnell M; Gentry-Maharaj A; Ford J; Gunu R; Soromani C; Hasenbrink G; Jacobs I; Dawnay A; Widschwendter M; Lichtenberg-Fraté H; Menon U
Endocr Relat Cancer; 2012 Apr; 19(2):137-47. PubMed ID: 22199143
[TBL] [Abstract][Full Text] [Related]
32. Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up.
Zhang X; Tworoger SS; Eliassen AH; Hankinson SE
Breast Cancer Res Treat; 2013 Feb; 137(3):883-92. PubMed ID: 23283524
[TBL] [Abstract][Full Text] [Related]
33. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women.
Zeleniuch-Jacquotte A; Bruning PF; Bonfrer JM; Koenig KL; Shore RE; Kim MY; Pasternack BS; Toniolo P
Am J Epidemiol; 1997 Jun; 145(11):1030-8. PubMed ID: 9169912
[TBL] [Abstract][Full Text] [Related]
34. Endogenous Circulating Sex Hormone Concentrations and Colon Cancer Risk in Postmenopausal Women: A Prospective Study and Meta-Analysis.
Mori N; Keski-Rahkonen P; Gicquiau A; Rinaldi S; Dimou N; Harlid S; Harbs J; Van Guelpen B; Aune D; Cross AJ; Tsilidis KK; Severi G; Kvaskoff M; Fournier A; Kaaks R; Fortner RT; Schulze MB; Jakszyn P; Sánchez MJ; Colorado-Yohar SM; Ardanaz E; Travis R; Watts EL; Masala G; Krogh V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita B; Gram IT; Waaseth M; Gunter MJ; Murphy N
JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34805742
[TBL] [Abstract][Full Text] [Related]
35. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.
Key T; Appleby P; Barnes I; Reeves G;
J Natl Cancer Inst; 2002 Apr; 94(8):606-16. PubMed ID: 11959894
[TBL] [Abstract][Full Text] [Related]
36. Added Value of Serum Hormone Measurements in Risk Prediction Models for Breast Cancer for Women Not Using Exogenous Hormones: Results from the EPIC Cohort.
Hüsing A; Fortner RT; Kühn T; Overvad K; Tjønneland A; Olsen A; Boutron-Ruault MC; Severi G; Fournier A; Boeing H; Trichopoulou A; Benetou V; Orfanos P; Masala G; Pala V; Tumino R; Fasanelli F; Panico S; Bueno de Mesquita HB; Peeters PH; van Gills CH; Quirós JR; Agudo A; Sánchez MJ; Chirlaque MD; Barricarte A; Amiano P; Khaw KT; Travis RC; Dossus L; Li K; Ferrari P; Merritt MA; Tzoulaki I; Riboli E; Kaaks R
Clin Cancer Res; 2017 Aug; 23(15):4181-4189. PubMed ID: 28246273
[No Abstract] [Full Text] [Related]
37. Pre-diagnostic sex hormone levels and survival among breast cancer patients.
Kensler KH; Eliassen AH; Rosner BA; Hankinson SE; Brown M; Tamimi RM
Breast Cancer Res Treat; 2019 Apr; 174(3):749-758. PubMed ID: 30604001
[TBL] [Abstract][Full Text] [Related]
38. Flavonoid Intake and Plasma Sex Steroid Hormones, Prolactin, and Sex Hormone-Binding Globulin in Premenopausal Women.
Wu Y; Hankinson SE; Smith-Warner SA; Wang M; Eliassen AH
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31694190
[TBL] [Abstract][Full Text] [Related]
39. A Prospective Evaluation of Endogenous Sex Hormone Levels and Colorectal Cancer Risk in Postmenopausal Women.
Murphy N; Strickler HD; Stanczyk FZ; Xue X; Wassertheil-Smoller S; Rohan TE; Ho GY; Anderson GL; Potter JD; Gunter MJ
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26232761
[TBL] [Abstract][Full Text] [Related]
40. Prediagnostic Circulating Levels of Sex Steroid Hormones and SHBG in Relation to Risk of Ductal Carcinoma
Arthur RS; Xue X; Rohan TE
Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):1058-1066. PubMed ID: 32127398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
